What does MCDS stand for?
MCDS stands for Ministerial Council of Drug Strategy
This definition appears rarely
See other definitions of MCDS
Samples in periodicals archive:
On this website you will find information about the National Drug Strategy and the advisory structures that support the strategy; links to the current drug campaign sites with information on initiatives at national, state/territory or community levels; the key research and data components supporting the strategy; publications; and key links to relevant government, professional organisations and drug-related portal sites. What's New? Public consultation for draft National Drug Strategy 2016-2025 National Aboriginal Torres Strait Islander Peoples Drug Strategy 2014-2019 National Alcohol and other Drug Workforce Development Strategy 2015-2018 Framework for a National Response to New Psychoactive Substance National Guidelines for Medication-Assisted Treatment of Opioid Dependence National Pharmaceutical Drug Misuse Framework for Action (2012-2015) Updated Fetal Alcohol Spectrum Disorders in Australia: An Update Australian secondary students' use of tobacco, alcohol, and over-the-counter and illicit substances in 2011 National Tobacco Strategy 2012-2018 National Drug Strategy 2010-2015 Public consultation for draft National Drug Strategy 2016-2025 The Intergovernmental Committee on Drugs (IGCD) invites feedback on the draft National Drug Strategy 2016-2025. Public consultations for the National Alcohol Strategy 2016-2021 The consultation process for the development of the National Alcohol Strategy 2016-21 commenced on 15 October 2015 and will conclude on 20 November 2015. As part of the consultation process, the National Alcohol Strategy: Online Survey is available. National Drug Strategy 2010-2015 The Ministerial Council on Drug Strategy.
The disproportionate expenditure in relation to law-enforcement remains despite the Ministerial Council on Drug Strategy (2001) endorsing the statement that “treatment is one of the most effective strategies for preventing drug use, crime and the next generation of problems” . The cost effectiveness of addressing drug problems through treatment is supported by research from the United States which found that for every $1 invested in addiction treatment programs, a return in excess of $12 in the reduction of crime, criminal justice costs and health care savings could be made .
While there are indications that such benefits would result from a change in controlled availability, these are based on a small number of inconclusive studies. They also addressed concerns such as the following: there may be leakage of government supply to street market; expansion of the program to larger numbers raises concerns about subjects having to be given "take-away" heroin; providing heroin to users in a supervised clinical setting may not provide an answer to the relationship between heroin and crime in a realistic setting; many heroin users are involved with crime before they become involved with heroin; costs due to supplementing of welfare services will be increased; being able to receive heroin legally does not ameliorate the difficulties that users face due to lack of education, diminished vocational skills and deficient social skills. The Committee concluded that the risks can be minimized and are outweighed by potential benefits. The cost is estimated at approximately Aus$10,000 per person per year. The ministerial Council on Drug Strategy.